Skip to main content

Table 3 Stem cell targeting nanodrugs for HER2-positive breast cancer

From: Nanotechnology approaches to addressing HER2-positive breast cancer

Nanotechnology Stem cell target Therapy References
Conjugation of hyaluronic acid and grafting the doublecortin-like kinase 1 monoclonal antibody to the surface of nanoparticles CD44 receptors None Qiao et al. (2016)
Encapsulated polymeric nanoparticle surface modified with chitosan CD44 receptors Doxorubicin Rao et al. (2015)
Fluorescent micelles CD44 and EGRF Paclitaxel Gener et al. (2015)